Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Dan Kaufman

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0695
    CA La Jolla 92093
    Phone858-822-1777
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Zou L, Chen Q, Quanbeck Z, Bechtold JE, Kaufman DS. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016; 6:22868. PMID: 26980556.
        View in: PubMed
      2. Hermanson DL, Bendzick L, Kaufman DS. Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer. Methods Mol Biol. 2016; 1441:277-84. PMID: 27177674.
        View in: PubMed
      3. Hermanson DL, Bendzick L, Pribyl L, McCullar V, Vogel RI, Miller JS, Geller MA, Kaufman DS. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells. 2016 Jan; 34(1):93-101. PMID: 26503833.
        View in: PubMed
      4. Angelos MG, Kaufman DS. Pluripotent stem cell applications for regenerative medicine. Curr Opin Organ Transplant. 2015 Dec; 20(6):663-70. PMID: 26536430.
        View in: PubMed
      5. Li LB, Ma C, Awong G, Kennedy M, Gornalusse G, Keller G, Kaufman DS, Russell DW. Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther. 2016 Mar; 24(3):582-91. PMID: 26444081.
        View in: PubMed
      6. Hermanson DL, Kaufman DS. Utilizing chimeric antigen receptors to direct natural killer cell activity. Front Immunol. 2015; 6:195. PMID: 25972867.
        View in: PubMed
      7. Ferrell PI, Xi J, Ma C, Adlakha M, Kaufman DS. The RUNX1 +24 Enhancer and P1 Promoter Identify a Unique Subpopulation of Hematopoietic Progenitor Cells Derived from Human Pluripotent Stem Cells. Stem Cells. 2015 Apr; 33(4):1130-41. PMID: 25546363.
        View in: PubMed
      8. Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B. Identification of an ADAM17 Cleavage Region in Human CD16 (Fc?RIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells. PLoS One. 2015; 10(3):e0121788. PMID: 25816339.
        View in: PubMed
      9. Zou L, Kidwai FK, Kopher RA, Motl J, Kellum CA, Westendorf JJ, Kaufman DS. Use of RUNX2 Expression to Identify Osteogenic Progenitor Cells Derived from Human Embryonic Stem Cells. Stem Cell Reports. 2015 Feb 10; 4(2):190-8. PMID: 25680477.
        View in: PubMed
      10. Ye L, Chang YH, Xiong Q, Zhang P, Zhang L, Somasundaram P, Lepley M, Swingen C, Su L, Wendel JS, Guo J, Jang A, Rosenbush D, Greder L, Dutton JR, Zhang J, Kamp TJ, Kaufman DS, Ge Y, Zhang J. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014 Dec 4; 15(6):750-61. PMID: 25479750.
        View in: PubMed
      11. Ni Z, Knorr DA, Bendzick L, Allred J, Kaufman DS. Expression of chimeric receptor CD4? by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Stem Cells. 2014 Apr; 32(4):1021-31. PMID: 24307574; NIHMSID: NIHMS548658 [Available on 04/01/15].
        View in: PubMed
      12. Ferrell PI, Hexum MK, Kopher RA, Lepley MA, Gussiaas A, Kaufman DS. Functional assessment of hematopoietic niche cells derived from human embryonic stem cells. Stem Cells Dev. 2014 Jun 15; 23(12):1355-63. PMID: 24517837; PMCID: PMC4046207 [Available on 06/15/15].
        View in: PubMed
        View in: PubMed Central
      13. Geller MA, Knorr DA, Hermanson DA, Pribyl L, Bendzick L, McCullar V, Miller JS, Kaufman DS. Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. Cytotherapy. 2013 Oct; 15(10):1297-306. PMID: 23993303; NIHMSID: NIHMS492882.
        View in: PubMed
      14. Ran D, Lam K, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells. Blood. 2013 Jun 27; 121(26):5252-3. PMID: 23813938; PMCID: PMC3695367.
        View in: PubMed
        View in: PubMed Central
      15. Bock AM, Knorr D, Kaufman DS. Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs). J Vis Exp. 2013; (74):e50337. PMID: 23644738.
        View in: PubMed
      16. Vallera DA, Zhang B, Gleason MK, Oh S, Weiner LM, Kaufman DS, McCullar V, Miller JS, Verneris MR. Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells. Cancer Biother Radiopharm. 2013 May; 28(4):274-82. PMID: 23611188; PMCID: PMC4209492.
        View in: PubMed
        View in: PubMed Central
      17. Knorr DA, Bock A, Brentjens RJ, Kaufman DS. Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy. Stem Cells Dev. 2013 Jul 1; 22(13):1861-9. PMID: 23421330; PMCID: PMC3685314.
        View in: PubMed
        View in: PubMed Central
      18. Knorr DA, Ni Z, Hermanson D, Hexum MK, Bendzick L, Cooper LJ, Lee DA, Kaufman DS. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med. 2013 Apr; 2(4):274-83. PMID: 23515118; PMCID: PMC3659832.
        View in: PubMed
        View in: PubMed Central
      19. Kaufman DS. Tu-mor(e) blood cells from human pluripotent stem cells. Blood. 2013 Feb 21; 121(8):1245-6. PMID: 23429981.
        View in: PubMed
      20. Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J, Zhang L, Swingen C, Vaughan JT, Kaufman DS, Zhang J. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation. 2013 Mar 5; 127(9):997-1008. PMID: 23371930; NIHMSID: NIHMS563761.
        View in: PubMed
      21. Ran D, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood. 2013 Apr 11; 121(15):2882-90. PMID: 23372166.
        View in: PubMed
      22. Simara P, Motl JA, Kaufman DS. Pluripotent stem cells and gene therapy. Transl Res. 2013 Apr; 161(4):284-92. PMID: 23353080; NIHMSID: NIHMS434129.
        View in: PubMed
      23. Ni Z, Knorr DA, Kaufman DS. Hematopoietic and nature killer cell development from human pluripotent stem cells. Methods Mol Biol. 2013; 1029:33-41. PMID: 23756940.
        View in: PubMed
      24. Xiong Q, Ye L, Zhang P, Lepley M, Swingen C, Zhang L, Kaufman DS, Zhang J. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ Res. 2012 Aug 3; 111(4):455-68. PMID: 22723295; NIHMSID: NIHMS459911.
        View in: PubMed
      25. Rao M, Ahrlund-Richter L, Kaufman DS. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cells. 2012 Jan; 30(1):55-60. PMID: 22069231.
        View in: PubMed
      26. Sjeklocha LM, Park CW, Wong PY, Roney MJ, Belcher JD, Kaufman DS, Vercellotti GM, Hebbel RP, Steer CJ. Erythroid-specific expression of ß-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. PLoS One. 2011; 6(12):e29110. PMID: 22216176; PMCID: PMC3247234.
        View in: PubMed
        View in: PubMed Central
      27. Waldron NN, Kaufman DS, Oh S, Inde Z, Hexum MK, Ohlfest JR, Vallera DA. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Mol Cancer Ther. 2011 Oct; 10(10):1829-38. PMID: 21862685; NIHMSID: NIHMS317817.
        View in: PubMed
      28. Liu Y, Wang X, Kaufman DS, Shen W. A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells. Biomaterials. 2011 Nov; 32(32):8058-66. PMID: 21821284; NIHMSID: NIHMS318158.
        View in: PubMed
      29. Undale A, Fraser D, Hefferan T, Kopher RA, Herrick J, Evans GL, Li X, Kakar S, Hayes M, Atkinson E, Yaszemski MJ, Kaufman DS, Westendorf JJ, Khosla S. Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow. J Orthop Res. 2011 Dec; 29(12):1804-11. PMID: 21674605; NIHMSID: NIHMS301697.
        View in: PubMed
      30. Solh M, DeFor TE, Weisdorf DJ, Kaufman DS. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant. 2012 Jan; 18(1):106-12. PMID: 21703975.
        View in: PubMed
      31. Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, Wang X, Jameel MN, Zhang P, Swingen C, Kaufman DS, Zhang J. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells. 2011 Feb; 29(2):367-75. PMID: 21732493; NIHMSID: NIHMS392526.
        View in: PubMed
      32. Hexum MK, Tian X, Kaufman DS. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Methods Mol Biol. 2011; 767:433-47. PMID: 21822894.
        View in: PubMed
      33. Gori JL, McIvor RS, Kaufman DS. Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase. Bioeng Bugs. 2010 Nov-Dec; 1(6):434-6. PMID: 21468213; PMCID: PMC3056096.
        View in: PubMed
        View in: PubMed Central
      34. Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. J Virol. 2011 Jan; 85(1):43-50. PMID: 20962093; PMCID: PMC3014194.
        View in: PubMed
        View in: PubMed Central
      35. Kaufman DS. HIF hits Wnt in the stem cell niche. Nat Cell Biol. 2010 Oct; 12(10):926-7. PMID: 20885419.
        View in: PubMed
      36. Islam MS, Ni Z, Kaufman DS. Use of human embryonic stem cells to understand hematopoiesis and hematopoietic stem cell niche. Curr Stem Cell Res Ther. 2010 Sep; 5(3):245-50. PMID: 20214557.
        View in: PubMed
      37. Knorr DA, Kaufman DS. Pluripotent stem cell-derived natural killer cells for cancer therapy. Transl Res. 2010 Sep; 156(3):147-54. PMID: 20801411; NIHMSID: NIHMS230241.
        View in: PubMed
      38. Kopher RA, Penchev VR, Islam MS, Hill KL, Khosla S, Kaufman DS. Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone. 2010 Oct; 47(4):718-28. PMID: 20601304; NIHMSID: NIHMS225291.
        View in: PubMed
      39. Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, Kaufman DS. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol. 2010 Mar; 38(3):246-257.e1. PMID: 20067819; NIHMSID: NIHMS174937.
        View in: PubMed
      40. Tian X, Hexum MK, Penchev VR, Taylor RJ, Shultz LD, Kaufman DS. Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells. Stem Cells. 2009 Nov; 27(11):2675-85. PMID: 19711457; NIHMSID: NIHMS192108.
        View in: PubMed
      41. Gori JL, Tian X, Swanson D, Gunther R, Shultz LD, McIvor RS, Kaufman DS. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase. Gene Ther. 2010 Feb; 17(2):238-49. PMID: 19829316; NIHMSID: NIHMS145529.
        View in: PubMed
      42. Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009 Oct 22; 114(17):3513-23. PMID: 19652198; PMCID: PMC2766673.
        View in: PubMed
        View in: PubMed Central
      43. Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, DeFor TE, Dusenbery KE, Kaufman DS, Kersey JH, MacMillan ML, McGlave PB, Miller JS, Orchard PJ, Slungaard A, Tomblyn MR, Vercellotti GM, Verneris MR, Wagner JE, Weisdorf DJ. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol. 2009 Aug 1; 27(22):3634-41. PMID: 19581540; PMCID: PMC2720079.
        View in: PubMed
        View in: PubMed Central
      44. Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, Kaufman DS. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood. 2009 Jun 11; 113(24):6094-101. PMID: 19365083; PMCID: PMC2699231.
        View in: PubMed
        View in: PubMed Central
      45. Hill KL, Kaufman DS. Hematopoietic differentiation of human embryonic stem cells by cocultivation with stromal layers. Curr Protoc Stem Cell Biol. 2008 Sep; Chapter 1:Unit 1F.6. PMID: 18819084.
        View in: PubMed
      46. Martin CH, Woll PS, Ni Z, Zúñiga-Pflücker JC, Kaufman DS. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood. 2008 Oct 1; 112(7):2730-7. PMID: 18621931; PMCID: PMC2556609.
        View in: PubMed
        View in: PubMed Central
      47. Tian X, Kaufman DS. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Curr Opin Hematol. 2008 Jul; 15(4):312-8. PMID: 18536568.
        View in: PubMed
      48. Cameron CM, Harding F, Hu WS, Kaufman DS. Activation of hypoxic response in human embryonic stem cell-derived embryoid bodies. Exp Biol Med (Maywood). 2008 Aug; 233(8):1044-57. PMID: 18535160.
        View in: PubMed
      49. Bera TK, Saint Fleur A, Ha D, Yamada M, Lee Y, Lee B, Hahn Y, Kaufman DS, Pera M, Pastan I. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells Dev. 2008 Apr; 17(2):325-32. PMID: 18447647.
        View in: PubMed
      50. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant. 2008 Mar; 14(3):282-9. PMID: 18275894; NIHMSID: NIHMS41246.
        View in: PubMed
      51. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol. 2008; 430:119-33. PMID: 18370295.
        View in: PubMed
      52. Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL, Moon RT, Kaufman DS. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood. 2008 Jan 1; 111(1):122-31. PMID: 17875805; PMCID: PMC2200802.
        View in: PubMed
        View in: PubMed Central
      53. Wilber A, Linehan JL, Tian X, Woll PS, Morris JK, Belur LR, McIvor RS, Kaufman DS. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells. 2007 Nov; 25(11):2919-27. PMID: 17673526.
        View in: PubMed
      54. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007 Apr 1; 109(7):2688-92. PMID: 17132724.
        View in: PubMed
      55. Cameron CM, Hu WS, Kaufman DS. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng. 2006 Aug 5; 94(5):938-48. PMID: 16547998.
        View in: PubMed
      56. Anderson JS, Bandi S, Kaufman DS, Akkina R. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology. 2006; 3:24. PMID: 16623949; PMCID: PMC1462997.
        View in: PubMed
        View in: PubMed Central
      57. Tian X, Woll PS, Morris JK, Linehan JL, Kaufman DS. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells. 2006 May; 24(5):1370-80. PMID: 16456127.
        View in: PubMed
      58. Qiu C, Hanson E, Olivier E, Inada M, Kaufman DS, Gupta S, Bouhassira EE. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol. 2005 Dec; 33(12):1450-8. PMID: 16338487.
        View in: PubMed
      59. Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman DS. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev. 2005 Dec; 14(6):643-55. PMID: 16433619.
        View in: PubMed
      60. Narayan AD, Chase JL, Lewis RL, Tian X, Kaufman DS, Thomson JA, Zanjani ED. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood. 2006 Mar 1; 107(5):2180-3. PMID: 16278307; PMCID: PMC1895718.
        View in: PubMed
        View in: PubMed Central
      61. Woll PS, Martin CH, Miller JS, Kaufman DS. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol. 2005 Oct 15; 175(8):5095-103. PMID: 16210613.
        View in: PubMed
      62. Martin CH, Kaufman DS. Synergistic use of adult and embryonic stem cells to study human hematopoiesis. Curr Opin Biotechnol. 2005 Oct; 16(5):510-5. PMID: 16095900.
        View in: PubMed
      63. Hematti P, Obrtlikova P, Kaufman DS. Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Exp Hematol. 2005 Sep; 33(9):980-6. PMID: 16140145.
        View in: PubMed
      64. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol. 2005; 290:149-62. PMID: 15361661.
        View in: PubMed
      65. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Med. 2005; 105:425-36. PMID: 15492412.
        View in: PubMed
      66. Tian X, Morris JK, Linehan JL, Kaufman DS. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol. 2004 Oct; 32(10):1000-9. PMID: 15504555.
        View in: PubMed
      67. Lakshmipathy U, Pelacho B, Sudo K, Linehan JL, Coucouvanis E, Kaufman DS, Verfaillie CM. Efficient transfection of embryonic and adult stem cells. Stem Cells. 2004; 22(4):531-43. PMID: 15277699.
        View in: PubMed
      68. Chen D, Lewis RL, Kaufman DS. Mouse and human embryonic stem cell models of hematopoiesis: past, present, and future. Biotechniques. 2003 Dec; 35(6):1253-61. PMID: 14682061.
        View in: PubMed
      69. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood. 2004 Feb 15; 103(4):1325-32. PMID: 14563647.
        View in: PubMed
      70. Kaufman DS, Thomson JA. Human ES cells--haematopoiesis and transplantation strategies. J Anat. 2002 Mar; 200(Pt 3):243-8. PMID: 12033728; PMCID: PMC1570686.
        View in: PubMed
        View in: PubMed Central
      71. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2001 Sep 11; 98(19):10716-21. PMID: 11535826; PMCID: PMC58532.
        View in: PubMed
        View in: PubMed Central
      72. Kaufman DS. A scientific rationale for human embryonic stem cell research. Yale J Health Policy Law Ethics. 2001; 2(1):109, 177-87. PMID: 12664943.
        View in: PubMed
      73. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001; 19(3):193-204. PMID: 11359944.
        View in: PubMed
      74. Kaufman DS, Schoon RA, Robertson MJ, Leibson PJ. Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci U S A. 1995 Jul 3; 92(14):6484-8. PMID: 7604018; PMCID: PMC41542.
        View in: PubMed
        View in: PubMed Central
      75. Kaufman DS, Schoon RA, Leibson PJ. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J Immunol. 1993 Feb 15; 150(4):1429-36. PMID: 8432986.
        View in: PubMed
      76. Kaufman DS, Schoon RA, Leibson PJ. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc Natl Acad Sci U S A. 1992 Sep 1; 89(17):8337-41. PMID: 1325654; PMCID: PMC49913.
        View in: PubMed
        View in: PubMed Central
      Dan's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Back to TOP